# Syndax Pharmaceuticals (SNDX): value investors who own it

1 value investor held Syndax Pharmaceuticals in their Q2 2026 13F, led by Torray Investment Partners.

## 13F holders

| Manager | Portfolio | Value | Change | Quarters held |
| --- | --- | --- | --- | --- |
| Torray Investment Partners | 0.4% | $2.9m | Added +28% | 3 |

Source: SEC filings, via moatshark (https://www.moatshark.com/s/sndx). Values traded and returns are estimates. Not investment advice. Built 2026-10-23.